By expenditures
| Name | Title | Type |
|---|---|---|
| Kim Dolan | Chief Financial Officer | Auditee |
| Nick Zhou | CFO | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 369190 | 2024 | 2025-09-30 | Novogradac & Company LLP | $87.43M |
| 338241 | 2023 | 2025-01-15 | Novogradac & Company LLP | $81.10M |
| 19934 | 2022 | 2023-09-25 | Novogradac & Company LLP | $75.58M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 369190 | 2024 | 2025-09-30 | 1156809 | 2024-002 | Material Weakness | Yes | N |
| 369190 | 2024 | 2025-09-30 | 1156808 | 2024-001 | Material Weakness | Yes | E |
| 369190 | 2024 | 2025-09-30 | 1156807 | 2024-002 | Material Weakness | Yes | N |
| 369190 | 2024 | 2025-09-30 | 1156806 | 2024-001 | Material Weakness | Yes | E |
| 338241 | 2023 | 2025-01-15 | 1095804 | 2023-003 | Significant Deficiency | Yes | N |
| 338241 | 2023 | 2025-01-15 | 1095803 | 2023-001 | Material Weakness | - | E |
| 338241 | 2023 | 2025-01-15 | 1095802 | 2023-005 | Material Weakness | - | N |
| 338241 | 2023 | 2025-01-15 | 1095801 | 2023-004 | Material Weakness | Yes | E |
| 338241 | 2023 | 2025-01-15 | 1095800 | 2023-006 | Material Weakness | - | N |
| 338241 | 2023 | 2025-01-15 | 1095799 | 2023-003 | Significant Deficiency | Yes | N |
| 338241 | 2023 | 2025-01-15 | 1095798 | 2023-002 | Material Weakness | - | N |
| 338241 | 2023 | 2025-01-15 | 1095797 | 2023-001 | Material Weakness | Yes | E |
| 338241 | 2023 | 2025-01-15 | 519362 | 2023-003 | Significant Deficiency | Yes | N |
| 338241 | 2023 | 2025-01-15 | 519361 | 2023-001 | Material Weakness | - | E |
| 338241 | 2023 | 2025-01-15 | 519360 | 2023-005 | Material Weakness | - | N |
| 338241 | 2023 | 2025-01-15 | 519359 | 2023-004 | Material Weakness | Yes | E |
| 338241 | 2023 | 2025-01-15 | 519358 | 2023-006 | Material Weakness | - | N |
| 338241 | 2023 | 2025-01-15 | 519357 | 2023-003 | Significant Deficiency | Yes | N |
| 338241 | 2023 | 2025-01-15 | 519356 | 2023-002 | Material Weakness | - | N |
| 338241 | 2023 | 2025-01-15 | 519355 | 2023-001 | Material Weakness | Yes | E |
| 19934 | 2022 | 2023-09-25 | 598525 | 2022-002 | Material Weakness | Yes | E |
| 19934 | 2022 | 2023-09-25 | 598524 | 2022-001 | Significant Deficiency | Yes | N |
| 19934 | 2022 | 2023-09-25 | 598523 | 2022-002 | Material Weakness | Yes | E |
| 19934 | 2022 | 2023-09-25 | 598522 | 2022-001 | Significant Deficiency | Yes | N |
| 19934 | 2022 | 2023-09-25 | 598521 | 2022-004 | Significant Deficiency | - | N |
| 19934 | 2022 | 2023-09-25 | 598520 | 2022-003 | Material Weakness | - | E |
| 19934 | 2022 | 2023-09-25 | 598519 | 2022-004 | Significant Deficiency | - | N |
| 19934 | 2022 | 2023-09-25 | 22083 | 2022-002 | Material Weakness | Yes | E |
| 19934 | 2022 | 2023-09-25 | 22082 | 2022-001 | Significant Deficiency | Yes | N |
| 19934 | 2022 | 2023-09-25 | 22081 | 2022-002 | Material Weakness | Yes | E |
| 19934 | 2022 | 2023-09-25 | 22080 | 2022-001 | Significant Deficiency | Yes | N |
| 19934 | 2022 | 2023-09-25 | 22079 | 2022-004 | Significant Deficiency | - | N |
| 19934 | 2022 | 2023-09-25 | 22078 | 2022-003 | Material Weakness | - | E |
| 19934 | 2022 | 2023-09-25 | 22077 | 2022-004 | Significant Deficiency | - | N |